Baseline characteristics of participants in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Citation
Rh. Grimm et al., Baseline characteristics of participants in the Antihypertensive and LipidLowering Treatment to Prevent Heart Attack Trial (ALLHAT), HYPERTENSIO, 37(1), 2001, pp. 19-27
Citations number
28
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
HYPERTENSION
ISSN journal
0194911X → ACNP
Volume
37
Issue
1
Year of publication
2001
Pages
19 - 27
Database
ISI
SICI code
0194-911X(200101)37:1<19:BCOPIT>2.0.ZU;2-S
Abstract
Diuretics and beta -blockers have been shown to reduce the risk of cardiova scular morbidity and mortality in people with hypertension in long-term cli nical trials. No study has compared newer more costly antihypertensive agen ts (calcium antagonists, ACE inhibitors, and a-adrenergic blockers) with di uretics for reducing the incidence of cardiovascular disease in an ethnical ly diverse group of middle-aged and elderly hypertensive patients. The stud y is a randomized, double-blind, active-controlled clinical trial designed to determine whether the incidence of the primary outcome, fatal coronary h eart disease or nonfatal myocardial infarction, differs between treatment i nitiation with a diuretic versus each of 3 other antihypertensive drugs. Me n and women aged greater than or equal to 55 years with at least 1 other ca rdiovascular disease risk factor were randomly assigned to chlorthalidone ( 12.5 to 25 mg/d), amlodipine (2.5 to 10 mg/d), lisinopril (10 to 40 mg/d), or doxazosin (2 to 8 mg/d) for planned follow-up of 4 to 8 years. This repo rt describes the baseline characteristics of the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants. A total of 42 448 participants were randomized from 625 sites in the United S tates, Canada, Puerto Rico, and the US Virgin Islands. The mean age was 67 years, with 35% aged greater than or equal to 70 years. Among those randomi zed, 36% were black, 19% were Hispanic, and 47% were women. The sample incl udes a high proportion of people with diabetes (36%), patients with existin g cardiovascular disease (47%), and smokers (22%). There were no important differences between the randomized treatment groups at baseline. ALLHAT wil l add greatly to our understanding of the management of hypertension by pro viding an answer to the following question: are newer antihypertensive agen ts similar, superior, or inferior to traditional treatment with diuretics?